Effect of Cefoperazone/Sulbactam on Blood Coagulation Function in Infected Emergency Department Patients and the Necessity of Vitamin K1 (VK1) Preventive Intervention: A Single-Center, Retrospective Analysis

Xupeng Shao; Yuanyuan Ren; Na Xie; Kailiang Fan; Haiyan Sun; Jiamin Lu; Jiuxiang Wei; Xincheng Tian

doi:10.12659/MSM.939203

05 June 2023: Database Analysis

Effect of Cefoperazone/Sulbactam on Blood Coagulation Function in Infected Emergency Department Patients and the Necessity |of Vitamin K1 (VK1) Preventive Intervention: A Single-Center, Retrospective Analysis

Xupeng Shao ^1ABCDEFG , Yuanyuan Ren ^1B , Na Xie ^1BC , Kailiang Fan ^1A* , Haiyan Sun ^1EF , Jiamin Lu ^2E , Jiuxiang Wei ^2F , Xincheng Tian ^2E

DOI: 10.12659/MSM.939203

Med Sci Monit 2023; 29:e939203

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 4 Coagulation dysfunction started from day 2. Overall, 195 cases were documented between days 2 and 19, accounting for approximately 99% of cases.

Back to the Article

Effect of Cefoperazone/Sulbactam on Blood Coagulation Function in Infected Emergency Department Patients and the Necessity |of Vitamin K1 (VK1) Preventive Intervention: A Single-Center, Retrospective Analysis

Your Privacy